In short. Vascular occlusion is the loss of blood supply to skin, or rarely the eye, when an injectable filler enters or compresses an artery. It is uncommon: recognition and referral are measured in minutes. Severe pain out of proportion to the injection, or skin turning white, grey, mottled or dusky, needs immediate assessment; any change in vision needs emergency care now.
Key points
- An injectable filler can enter or compress an artery and starve tissue of blood.
- It is uncommon, but not rare enough to be treated as theoretical.
- Pain out of proportion, or skin turning white, grey, mottled or dusky, needs immediate assessment.
- Any change in vision is an emergency on its own, and is not reliably reversible.
- Dissolving the filler is part of management, not a guarantee of the outcome.
Every filler consultation involves a discussion of risk, and one risk deserves more than a sentence. An injectable filler can obstruct a blood vessel, and the tissue that vessel supplies is then starved of blood. It is uncommon. It is also the reason filler belongs in a setting that can act immediately, and the reason every patient should know what to look for before the injection rather than after it.
How does an injectable filler block a blood vessel?
Filler placed in the face can enter or compress an artery. When it does, the blood supply to a region of skin is interrupted. In the skin the result is a colour change and pain that worsen rather than settle. In the rare case where the obstruction affects the blood supply to the eye, vision can be affected, and that outcome is not reliably reversible.
What are the warning signs?
The classic warning is pain that is severe and out of proportion to the injection, combined with a change in skin colour: white, grey, mottled or dusky. The change may be patchy, and it may not appear immediately. Any change in vision is an emergency on its own. These signs require immediate assessment, not a photograph sent to a clinic and not an appointment next week.
Which findings mean emergency care now?
| What you notice | What it may mean | What to do |
|---|---|---|
| Severe pain out of proportion to the injection | Blood supply to an area of skin is interrupted | Immediate assessment; do not wait for a review appointment |
| Skin turning white, grey, mottled or dusky | The same interruption; the change may be patchy and may not appear immediately | Immediate assessment; do not send a photograph and wait |
| Any change in vision, partial or temporary | The obstruction has reached the blood supply of the eye, which is not reliably reversible | Emergency care immediately, without waiting |
| Skin breakdown, blistering or a dusky patch over a treated area | Tissue is being starved of blood | Immediate assessment |
| The area getting worse rather than better | The process is not settling | Immediate assessment rather than waiting |
What the treating team does
Management is time-critical and includes stopping the injection, measures to improve blood flow to the area, and, where the product is a dissolvable gel filler, dissolving it with the enzyme that acts on that class. In some cases further treatment in hospital is needed. This is one reason a dissolvable class is the safer default for a first treatment, and one reason filler should be performed where hospital-level support exists rather than in a setting that has none.
The two habits that most reduce the risk of a serious outcome are treating conservatively and using a class that can be dissolved. A conservative plan means less product in a mobile, vessel-rich area. A dissolvable class means that if something does go wrong, there is an intervention available rather than only waiting.
What this means for your decision
It does not mean filler is unreasonably dangerous. It means the setting matters: ask what the clinic would do if this happened, who would be contacted, what equipment is on site, and how quickly you could be seen. A clinic that can answer specifically is prepared for it. A clinic that answers vaguely has not thought about it, and that is information about the practice.
Being honest about the limits of reassurance
Most filler treatments are uneventful, and most patients never encounter this. But the honest position is that no injector can guarantee it will not happen, and that the outcome depends on recognition and speed. That is why the signs are stated plainly on this site, in the guides, and in the review section that appears on every page.
Sources
- American Academy of Dermatology — injectable filler safety information
- NICE — guidance on dermal filler complications and urgent referral
- Medicines and Healthcare products Regulatory Agency — dermal filler safety information
Internal links
Frequently asked questions
How common is vascular occlusion?
It is uncommon, and it is not rare enough to be treated as theoretical. Its consequences depend heavily on which vessel is involved and how quickly it is recognised, which is why every patient should know the signs before treatment rather than being introduced to them afterwards.
What should I do if I notice the signs?
Contact the treating team immediately and go to the hospital. Do not wait for a review appointment, and do not assume it will settle. The measures that help are time-sensitive, and delay is the factor that makes the outcome worse.
Does dissolving the filler fix it?
Dissolution is part of the immediate management where the product is a hyaluronic-acid filler. It is not the only measure, and it does not guarantee the outcome. It is one reason the reversible class is the safer default for a first treatment.
Risks & Limitations
- Vascular occlusion — filler blocking a blood vessel. This is a time-critical emergency that can cause skin loss and, rarely, vision loss.
- Nodules, lumps or delayed inflammatory reactions, which may need treatment or dissolution.
- Infection at the injection site.
- Asymmetry or over-correction. Over-treatment is harder to correct than under-treatment.
- Migration of filler away from the intended area.
- Bruising and swelling. All filler results are temporary and maintenance treatment is required.
- Filler cannot correct tissue ptosis, and a thread lift is not a facelift.
When to Seek Care
- Severe pain out of proportion to the injection, or skin turning white, grey, mottled or dusky — a vascular emergency; seek care immediately.
- Any change in vision — seek emergency care immediately.
- Fever, spreading redness, warmth or pus at an injection site.
- A hard, painful lump that is growing, or redness and swelling appearing weeks to months after treatment.
- Skin breakdown, blistering or a dusky patch over a treated area.
References & Further Reading
- American Academy of Dermatology (AAD) — injectable safety information
- American Society of Plastic Surgeons (ASPS) — dermal filler guidance
- U.S. Food and Drug Administration (FDA) — approved dermal filler products
- National Medical Products Administration (NMPA, China) — approved product status
- Chongqing West District Hospital — Plastic Surgery & Aesthetics Medical Center
This page is patient education, not medical advice, and it does not cite individual studies. Discuss your own case with a qualified clinician. To arrange an assessment at Chongqing West District Hospital, see Contact & Consultation.